3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole

C102H76N26O — CID 157215205

IUPAC3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole
SMILESCC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.Cc1ccncc1-c1ccc2[nH]nc(-c3nc4c(-c5ccncc5)cccc4[nH]3)c2c1.Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1
InChIInChI=1S/C29H25N7O.C25H18N6.C24H17N7.C24H16N6/c1-17(2)12-26(37)32-21-13-20(15-31-16-21)19-6-7-24-23(14-19)28(36-35-24)29-33-25-5-3-4-22(27(25)34-29)18-8-10-30-11-9-18;1-15-7-10-27-14-20(15)17-5-6-21-19(13-17)24(31-30-21)25-28-22-4-2-3-18(23(22)29-25)16-8-11-26-12-9-16;25-17-10-16(12-27-13-17)15-4-5-20-19(11-15)23(31-30-20)24-28-21-3-1-2-18(22(21)29-24)14-6-8-26-9-7-14;1-4-18(15-8-11-25-12-9-15)22-21(5-1)27-24(28-22)23-19-13-16(6-7-20(19)29-30-23)17-3-2-10-26-14-17/h3-11,13-17H,12H2,1-2H3,(H,32,37)(H,33,34)(H,35,36);2-14H,1H3,(H,28,29)(H,30,31);1-13H,25H2,(H,28,29)(H,30,31);1-14H,(H,27,28)(H,29,30)
InChIKeyASIJMMBVMZHXMS-UHFFFAOYSA-N
MW1681.91 g/mol
LogP21.80
Rot. Bonds15

About 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole

3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole (PubChem CID 157215205) has the molecular formula C102H76N26O and a molecular weight of 1681.91 g/mol. Its IUPAC name is 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole.

Molecular Properties

Compound Name3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole
PubChem CID157215205
Molecular FormulaC102H76N26O
Molecular Weight1681.91 g/mol
Exact Mass1680.67
IUPAC Name3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole
SMILESCC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.Cc1ccncc1-c1ccc2[nH]nc(-c3nc4c(-c5ccncc5)cccc4[nH]3)c2c1.Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1
InChIInChI=1S/C29H25N7O.C25H18N6.C24H17N7.C24H16N6/c1-17(2)12-26(37)32-21-13-20(15-31-16-21)19-6-7-24-23(14-19)28(36-35-24)29-33-25-5-3-4-22(27(25)34-29)18-8-10-30-11-9-18;1-15-7-10-27-14-20(15)17-5-6-21-19(13-17)24(31-30-21)25-28-22-4-2-3-18(23(22)29-25)16-8-11-26-12-9-16;25-17-10-16(12-27-13-17)15-4-5-20-19(11-15)23(31-30-20)24-28-21-3-1-2-18(22(21)29-24)14-6-8-26-9-7-14;1-4-18(15-8-11-25-12-9-15)22-21(5-1)27-24(28-22)23-19-13-16(6-7-20(19)29-30-23)17-3-2-10-26-14-17/h3-11,13-17H,12H2,1-2H3,(H,32,37)(H,33,34)(H,35,36);2-14H,1H3,(H,28,29)(H,30,31);1-13H,25H2,(H,28,29)(H,30,31);1-14H,(H,27,28)(H,29,30)
InChIKeyASIJMMBVMZHXMS-UHFFFAOYSA-N
XLogP21.80
TPSA387.68 Ų
H-Bond Donors10
H-Bond Acceptors18
Rotatable Bonds15
Heavy Atoms129
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001681.91
LogP ≤ 521.80
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1018

Analyze 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole?
The IUPAC name of 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole (CID 157215205) is 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole.
What is the SMILES notation for 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole?
The canonical SMILES for 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole is CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.Cc1ccncc1-c1ccc2[nH]nc(-c3nc4c(-c5ccncc5)cccc4[nH]3)c2c1.Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1.
What is the InChIKey of 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole?
The InChIKey is ASIJMMBVMZHXMS-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H25N7O.C25H18N6.C24H17N7.C24H16N6/c1-17(2)12-26(37)32-21-13-20(15-31-16-21)19-6-7-24-23(14-19)28(36-35-24)29-33-25-5-3-4-22(27(25)34-29)18-8-10-30-11-9-18;1-15-7-10-27-14-20(15)17-5-6-21-19(13-17)24(31-30-21)25-28-22-4-2-3-18(23(22)29-25)16-8-11-26-12-9-16;25-17-10-16(12-27-13-17)15-4-5-20-19(11-15)23(31-30-20)24-28-21-3-1-2-18(22(21)29-24)14-6-8-26-9-7-14;1-4-18(15-8-11-25-12-9-15)22-21(5-1)27-24(28-22)23-19-13-16(6-7-20(19)29-30-23)17-3-2-10-26-14-17/h3-11,13-17H,12H2,1-2H3,(H,32,37)(H,33,34)(H,35,36);2-14H,1H3,(H,28,29)(H,30,31);1-13H,25H2,(H,28,29)(H,30,31);1-14H,(H,27,28)(H,29,30).
What are the key properties of 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole?
3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole has a molecular weight of 1681.91 g/mol, XLogP of 21.80, 15 rotatable bonds, 10 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 3-methyl-N-[5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-3-pyridinyl]butanamide;2-[5-(4-methyl-3-pyridinyl)-1H-indazol-3-yl]-4-pyridin-4-yl-1H-benzimidazole;5-[3-(4-pyridin-4-yl-1H-benzimidazol-2-yl)-1H-indazol-5-yl]pyridin-3-amine;4-pyridin-4-yl-2-(5-pyridin-3-yl-1H-indazol-3-yl)-1H-benzimidazole is sourced from PubChem (CID 157215205), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).